-
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
Read articleNicholas van As, Binnaz Yasar, Clare Griffin, Jaymini Patel, Alison C. Tree, Peter Ostler, Hans vander Voet, Daniel Ford, Shaun Tolan, Paula Wells, Rana Mahmood, Mathias Winkler, Andrew Chan, Alan Thompson, Chris Ogden, Olivia Naismith, Julia Pugh, Georgina Manning, Stephanie Brown, Stephanie Burnett, Emma Hall.
Published in European Urology, 2024
-
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
Read articleN. van As, C. Griffin, A. Tree, J. Patel, P. Ostler, H. van der Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, J. Armstrong, J. Staffurth, A. Martin, I. Dayes, P. Wells, D. Price, E. Williamson, J. Pugh, G. Manning, S. Brown, S. Burnett, and E. Hall
Published in The New England Journal of Medicine, 2024
-
Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT): Analysis of Toxicity and Quality of Life from a Prospective Study
Read articleStefano Arcangeli, Chiara Chissotti, Federica Ferrario, Raffaella Lucchini, Maria Belmonte, Giorgio Purrello, Riccardo Ray Colciago, Elena De Ponti, Valeria Faccenda, Denis Panizza
Published in International Journal of Radiation Oncology, Biology, Physics, 2024, July 04.
-
Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion
Read articleDe Bari, B.; Guibert, G.; Slimani, S.; Bashar, Y.; Risse, T.; Guisolan, N.; Trouillot, J.; Abel, J.; Weber, P.
Published in Curr. Oncol. 2024, 31, 962-974.
-
State of the art and future challenges of urethra‑sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature
Read articleJennifer Le Guevelou, Davide Giovanni Bosetti, Francesco Castronovo, Antonio Angrisani, Renaud de Crevoisier & Thomas Zilli
Published in World Journal of Urology, 2023, Sept 5th
-
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?
Read articleJohannes Berchtold , Carmen Winkler , Josef Karner , Michael Groher , Christoph Gaisberger, Felix Sedlmayer and Frank Wolf
Published in Strahlenther Onkol, 2023 Aug 25. (Online ahead of print)
-
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
Read articlePer Fransson, PhD, Per Nilsson, PhD, Adalsteinn Gunnlaugsson, MD, Lars Beckman, MD, Björn Tavelin, BSc, David Norman, BSc, Camilla Thellenberg-Karlsson, MD, Prof Morten Hoyer, MD, Magnus Lagerlund, MD, Jon Kindblom, MD, Claes Ginman, MD, Bengt Johansson, MD, Kirsten Björnlinger, MD, Mihajl Seke, MD, Måns Agrup, MD, Prof Björn Zackrisson, MD, Elisabeth Kjellén, MD, Prof Lars Franzén, MD, Prof Anders Widmark, MD
-
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Read articleDavid Dearnaley et al.